Small molecule agonists and antagonists for the LH and FSH receptors

Expert Opinion on Therapeutic Patents

Volumn 15, Issue 11, 2005, Pages 1555-1564

  Guo, Tao ^a  

^a PHARMACOPEIA INC   (United States)

Author keywords

Agonist; Antagonist; Contraception; Follicle stimulating hormone (FSH); FSHR; Infertility; LHR; Luteinising hormone (LH)

Indexed keywords

1 SULFONYLPIPERAZINE 2 CARBOXAMIDE DERIVATIVE; ALPHA AMINOCARBOXAMIDE DERIVATIVE; ARYLSULFONIC ACID DERIVATIVE; BETA AMINOCARBOXAMIDE DERIVATIVE; CHORIONIC GONADOTROPIN; FOLLITROPIN; FOLLITROPIN RECEPTOR; FOLLITROPIN RECEPTOR AGONIST; FOLLITROPIN RECEPTOR ANTAGONIST; G PROTEIN COUPLED RECEPTOR; HORMONE RECEPTOR AFFECTING AGENT; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; INDOLIDAN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; LUTEINIZING HORMONE RECEPTOR AGONIST; LUTEINIZING HORMONE RECEPTOR ANTAGONIST; MILRINONE; ORAL CONTRACEPTIVE AGENT; ORG 41841; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; SULFONIC ACID DERIVATIVE; TETRAHYDROQUINOLINE DERIVATIVE; THIAZOLIDINONE DERIVATIVE; THIENOPYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIRTH CONTROL; COMBINATORIAL CHEMISTRY; DOSE RESPONSE; DRUG EFFICACY; DRUG STRUCTURE; FEMALE; FOLLITROPIN RELEASE; HIGH THROUGHPUT SCREENING; HUMAN; HYPOPHYSIS; INFERTILITY; LUTEINIZING HORMONE RELEASE; MALE; MOLECULAR BIOLOGY; NONHUMAN; ORAL CONTRACEPTION; OVARY FOLLICLE DEVELOPMENT; REPRODUCTION; REVIEW; SIDE EFFECT; SPERMATOGENESIS; STRUCTURE ACTIVITY RELATION;

EID: 27944471033     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.15.11.1555     Document Type: Review

References (64)

1. PIERCE JG, PARSONS TF: Glycoprotein hormones: structure and function. Ann. Rev. Biochem. (1981) 50:465-495.
2. FIDDES JC, TALMADGE K: Structure, expression, and evolution of the genes for the human glycoprotein hormones. Recent Prog. Horm. Res. (1984) 40:43-78.
3. WU H, LUSTBADER JW, LIU Y, CANFIELD RE, HENDRICKSON WA: Structure of human chorionic gonadotropin at 2.6 Å resolution from MAD analysis of the selenomethionyl protein. Structure (1994) 2:545-558.
4. LAPTHORN AJ, HARRIS DC, LITTLEJOHN A et al.: Crystal structure of human chorionic gonadotropin. Nature (1994) 369:455-461.
5. FOX KM, DIAS JA, VAN ROEY P: Three-dimensional structure of human follicle-stimulating hormone. Mol. Endocrinol. (2001) 15:378-389.
6. SIMONI M, GROMOLL J, NIESCHLAG E: The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr. Rev. (1997) 18:739-773.
7. DIAS JA, COHEN BD, LINDAU-SHEPARD B et al.: Molecular, structural, and cellular biology of follitropin and follitropin receptor. Vitam. Horm. (2002) 64:249-322.
8. SZKUDLINSKI MW, FREMONT V, RONIN C, WEINTRAUB BD: Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol. Rev. (2002) 82:473-502.
9. ASCOLI M, FANELLI F, SEGALOFF DL: The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr. Rev. (2002) 23:141-174.
10. STRADER CD, FONG TM, TOTA MR, et al.: Structure and function of G protein coupled receptors. Ann. Rev. Biochem. (1994) 63:101-132.
11. FAN QR, HENDRICKSON WA: Structure of human follicle-stimulating hormone in complex with its receptor. Nature (2005) 433:269-277.
12. BRAUN T, SCHOFIELD PR, SPRENGEL R: Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J. (1991) 10:1885-1890.
13. DUFAU ML, CATT KJ: Gonadotropin receptors and regulation of steroidogenesis in the testis and ovary. Vitam. Horm. (1978) 36:461-592.
14. DORRINGTON JH, ARMSTRONG DT: Effects of FSH on gonadal functions. Recent Prog. Horm. Res. (1979) 35:301-342.
15. ERICKSON GF, MAGOFFIN DA, DYER CA, HOFEDITZ C: The ovarian androgen producing cells: a review of structure/function relationships. Endocr. Rev. (1985) 6:371-399.
16. THEMMEN APN, HUHTANIEMI IT: Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr. Rev. (2000) 21:551-583.
17. PLANT TM, MARSHALL GR: The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr. Rev. (2001) 22:764-786.
18. MA X, DONG Y, MATZUK MM, KUMAR TR: Targeted disruption of luteinizing hormone β-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility. Proc. Natl. Acad. Sci. USA (2004) 101:17294-17299.
19. ZHANG FP, POUTANEN M, WILBERTZ J, HUHTANIEMI I: Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol. Endocrinol. (2001) 15:172-183.
20. LEI ZM, MISHRA S, ZOU W et al.: Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol. Endocrinol. (2001) 15:184-200.
21. ABEL MH, HUHTANIEMI I, PAKARINEN P, KUMAR TR, CHARLTON HM: Age-related uterine and ovarian hypertrophy in FSH receptor knockout and FSHβ subunit knockout mice. Reproduction (2003) 125:165-173.
22. ABEL MH, WOOTTON AN, WILKINS V et al.: The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology (2000) 141:1795-1803.
23. DANILOVICH N, BABU PS, XING W et al.: Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology (2000) 141:4295-4308.
24. KUMAR TR, WANG Y, LU N, MATZUK MM: Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat. Genet. (1997) 15:201-204.
25. KRISHNAMURTHY H, DANILOVICH N, MORALES CR, SAIRAM MR: Qualitative and quantitative decline in spermatogenesis of the follicle-stimulating hormone receptor knockout (FORKO) mouse. Biol. Reprod. (2000) 62:1146-1159.
26. GROVER A, SMITH CE, GREGORY M et al.: Effects of FSH receptor deletion on epididymal tubules and sperm morphology, numbers, and motility. Mol. Reprod. Develop. (2005) 72:135-144.
27. TAPANAINEN JS, AITTOMAKI K, MIN J, VASKIVUO T, HUHTANIEMI IT: Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat. Genet. (1997) 15:205-206.
28. PALAGIANO A, NESTI E, PACE L: FSH: urinary and recombinant. Eur. J. Obstet. Gynecol. Reprod. Biol. (2004) 115:S30-S33.
29. INSLER V: Gonadotropin therapy: new trends and insights. Internatl. J. Fertil. (1988) 33:85-97.
30. NAVOT D, ROSENWAKS Z: The use of follicle-stimulating hormone for controlled ovarian hyperstimulation in in vitro fertilization. J. In Vitro Fertil. Embryo Transfer (1988) 5:3-13.
31. MORSE JH, LUSTBADER JW, HARRINGTON JW, CANFIELD RE: Heterogeneity of proteins in commercial preparations of human chorionic gonadotropin (hCG) demonstrated by western blotting. Am. J. Reprod. Immunol. Microbiol. (1988) 17:134-140.
32. WIESAK T: Role of LH in controlled ovarian stimulation. Reprod. Biol. (2002) 2:215-227.
33. COHEN J: A short review of ovarian stimulation in assisted reproductive techniques. Reprod. Biomed. (2003) 6:361-366.
34. HULL M: Experience with F.S.H. treatment alone in an I.V.F. program. World Congress on In vitro Fertilization and Assisted Reproduction, 9th. Vienna (3-7 April 1995):77-82.
35. MARRS R, MELDRUM D, MUASHER S et al.: Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod. Biomed. Online (2004) 8:175-182.
36. CHAPPEL S: Biochemical and biological characterization of LH and FSH expressed by recombinant DNA technology. In: Molecular Biology of Brain and Endocrine Peptidergic Systems. Chretien M, McKerns KW (Eds) Plenum Publishing, NY, USA (1988):275-288.
37. GLASIER A: Contraception - past and future. Nat. Cell. Biol. Nat. Med. Fertil. Suppl. (2002) S3-S6.
38. POTTS M: The myth of a male pill. Nat. Med. (1996) 2:398-399.
39. GLASIER AF, ANAKWE R, EVERINGTON D et al.: Would women trust their partners to use a male pill? Hum. Reprod. (2000) 15:646-649.
40. BRADY BM, ANDERSON RA: Advances in male contraception. Expert Opin. Investig. Drugs (2002) 11:333-344.
41. SUGG EE: Nonpeptide agonists for peptide receptors: lessons from ligands. Ann. Rep. Med. Chem. (1997) 32:277-283.
42. BEELEY NR: Can peptides be mimicked? Drug Discov. Today (2000) 5:354-363.
43. BRASIER A, TATE J, HABENER J: Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. BioTechniques (1989) 7:1116-1122.
44. BENZAKOUR O, KANTHOU C, DENNEHY U et al.: Evaluation of the use of the luciferase-reporter-gene system for gene-regulation studies involving cyclic AMP-elevating agents. Biochem. J. (1995) 309:385-387.
45. DOLLE RE: Comprehensive survey of combinatorial library synthesis: 2003. J. Comb. Chem. (2004) 6:623-679.
46. DOLLE RE: Comprehensive survey of combinatorial library synthesis: 2002. J. Comb. Chem. (2003) 5:693-753.
47. DOLLE RE: Comprehensive survey of combinatorial library synthesis: 2001. J. Comb. Chem. (2002) 4:369-418.
48. DOLLE RE: Comprehensive survey of combinatorial library synthesis: 2000. J. Comb. Chem. (2001) 3:477-517.
49. DOLLE RE: Comprehensive survey of combinatorial library synthesis: 1999. J. Comb. Chem. (2000) 2:383-433.
50. DOLLE RE, NELSON KH JR: Comprehensive survey of combinatorial library synthesis: 1998. J. Comb. Chem. (1999) 1:235-292.
51. DOLLE RE: Comprehensive survey of chemical libraries yielding enzyme inhibitors, receptor agonists and antagonists, and other biologically active agents: 1992 through 1997. Mol. Divers. (1998) 3:199-233.
52. VAN STRATEN NC, SCHOONUS-GERRITSMA GG, VAN SOMEREN RG et al.: The first orally active low molecular weight agonists for the LH receptor: thienopyr(im)idines with therapeutic potential for ovulation induction. ChemBioChem (2002) 3:1023-1026.
53. JORAND-LEBRUN C, BRUGGER N, SHROFF H et al.: Pyrazole derivatives as new LH receptor agonists. 226th ACS Meeting, New York, USA (2003) MEDI320.
54. ALOUSI AA, STANKUS GP, STUART JC, WALTON LH: Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species. J. Cardiovasc. Pharmacol. (1983) 5:804-811.
55. KAUFFMAN RF, ROBERTSON DW, FRANKLIN RB et al.: Indolidan: a potent, long-acting cardiotonic and inhibitor of Type IV cyclic AMP phosphodiesterase. Cardiovasc. Drug Rev. (1990) 8:303-322.
56. MCKENNA SD, PIETROPAOLO M, TOS EG et al.: Pharmacological inhibition of phosphodiesterase 4 triggers ovulation in follicle-stimulating hormone-primed rats. Endocrinology (2005) 146:208-214.
57. MACLEAN D, HOLDEN F, DAVIS AM et al.: Agonists of the follicle stimulating hormone receptor from an encoded thiazolidinone library. J. Comb. Chem. (2004) 6:196-206.
58. JETTER J, KAO W, ROGERS J et al.: Synthesis and in vitro biology of novel 5-alkylated thiazolidinones as FSH agonists. 226th ACS Meeting, New York, USA (2003) MEDI319.
59. PELLETIER JC, ROGERS J, WROBEL J, SHEN E, MEADE E: Highly substituted gamma lactam follicle stimulating hormone (FSH) agonists from γ lactones: a one-pot, two-step stereoselective method involving Weinreb amidation and the Mitsunobu reaction. 226th ACS Meeting, New York, USA (2003) MEDI318.
60. GUO T, ADANG AEP, DOLLE RE et al.: Small molecule biaryl FSH receptor agonists. Part 1. Lead discovery via encoded combinatorial synthesis. Bioorg. Med. Chem. Lett. (2004) 14:1713-1716.
61. GUO T, ADANG AEP, DONG G et al.: Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesis. Bioorg. Med. Chem. Lett. (2004) 14:1717-1720.
62. VAN STRATEN NCR, VAN BERKEL TH, DEMONT DR et al.: Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor. J. Med. Chem. (2005) 48:1697-1700.
63. AREY BJ, DEECHER DC, SHEN ES et al.: Identification and characterization of a selective, nonpeptide follicle-stimulating hormone receptor antagonist. Endocrinology (2002) 143:3822-3829.
64. WROBEL J, GREEN D, JETTER J et al.: Synthesis of (bis)sulfonic acid, (bis)benzamides as follicle-stimulating hormone (FSH) antagonists. Bioorg. Med. Chem. (2002) 10:639-656.